February 12, 2013; 80 (7) In Focus
Spotlight on the February 12 Issue
Robert A. Gross
First published February 11, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318283bb2d
Spotlight on the February 12 Issue
Robert A. Gross
Neurology Feb 2013, 80 (7) 605; DOI: 10.1212/WNL.0b013e318283bb2d
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 80 no. 7 605
Print ISSN:
Online ISSN:
History:
- First Published February 11, 2013.
Copyright & Usage:
© 2013 American Academy of Neurology
Author Disclosures
- Robert A. Gross, MD, PhD, FAAN, Editor-in-Chief, Neurology®
- Robert A. Gross, MD, PhD, FAAN, Editor-in-Chief, Neurology®
Article usage
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS
- ALS dysphagia pathophysiology: Differential botulinum toxin response
- Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD
- Functional disturbance of the locomotor network in progressive supranuclear palsy
- A randomized controlled trial of intranasal ketamine in migraine with prolonged aura
- Cerebral atrophy in mild cognitive impairment and Alzheimer disease: Rates and acceleration
- CONTEMPORARY ISSUES
- Footnotes
- Info & Disclosures
Advertisement